News & Noteworthy
Explore our latest news and insights locally and around the globe.
Events
Soft Landing or False Dawn?
On November 15, 2022, Laly Kassa and Elizabeth Kearns, Co-heads of Planning, presented “Practical Planning Strategies”, a one-hour session on important planning techniques for getting your financial house in order and specific strategies for today’s economic environment.
Practical Planning Strategies | Presented by Laly Kassa & Elizabeth Kearns, Co-Heads of Planning
September 20, 2022 – While 2022 has been a difficult year for most investors, with rising interest rates and turbulent financial markets, market declines don’t last forever. Is now a riskier time to invest than it was a year ago, before the market downturn? Amy Raskin, Chief Investment Officer, answers this question and puts today’s market environment into context, focusing first on U.S. equities and then bonds and international equities.
Investment Strategies for a New Market Reality | Presented by Amy Raskin, Chief Investment Officer
3.21.2022 – Chevy Chase Trust was honored to host Georgetown Lombardi Cancer Center’s Dr. Michael Atkins and University of Pittsburgh’s Dr. Laura Ferris on the topic “Advances in Skin Cancer Prevention, Diagnosis & Treatment.” Learn ways to protect yourself and the innovative treatments being used today.
A Virtual Event: Advances in Skin Cancer Prevention, Diagnosis & Treatment
2.10.2022 – Watch to learn more about how to integrate charitable goals and tax-saving strategies into your overall financial and estate plans.
A Virtual Event: Maximize Your Impact: Charitable Giving with Strategy and Purpose in 2022
10.27.2021 – Looking to increase beneficiary well-being? Watch our Family Wealth & Well-Being virtual event to learn more.
A Virtual Event: “Family Wealth & Well-Being: Rethinking Traditional Inheritance Planning”
Chevy Chase Trust was pleased to host renowned author, journalist, and professor, Walter Isaacson for a conversation about his new book, The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of the Human Race. In the book, Mr. Isaacson showcases Jennifer Doudna, Ph.D., whose work on the gene-editing technology called CRISPR won her and Emmanuelle Charpentier the 2020 Nobel Prize in Chemistry and, Mr. Isaacson believes, will change the future of medicine.
Click on the link above to view the recording of the Chevy Chase Trust event featuring Mr. Isaacson’s description of Dr. Doudna’s journey of discovery, the life sciences revolution in which “molecules will become the next microchip,” the ethical issues associated with designer babies and much more. His remarks are followed by a question and answer session led by Amy Raskin, Chief Investment Officer, and Andrew Marshall, Vice President, both of Chevy Chase Trust.
Read our white paper on Investing in Disruptive Change: Personalized Medicine »
Read our white paper on Genomics »